STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Schrödinger to Announce First Quarter 2022 Financial Results on May 4

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will report its Q1 2022 financial results on May 4, 2022, after market close. The company will host a conference call at 4:30 p.m. ET to discuss the results. Schrödinger uses a physics-based software platform for drug and materials discovery, leading to rapid and cost-effective development. Founded in 1990, it collaborates with global biopharmaceutical and industrial firms, academic institutions, and government labs, employing over 650 staff across 70 countries.

Positive
  • Schrödinger's physics-based software platform enhances drug and materials discovery speed and cost-effectiveness.
  • The company engages with customers and collaborators in over 70 countries, indicating broad market penetration.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2022 financial results on Wednesday, May 4, 2022, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please dial (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 7896009. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 650 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com follow us on LinkedIn and Twitter, or visit our blog, Extrapolations.com.

Jaren Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Source: Schrödinger

FAQ

When will Schrödinger report its Q1 2022 financial results?

Schrödinger will report its Q1 2022 financial results on May 4, 2022.

What time is the Schrödinger conference call on May 4, 2022?

The conference call will take place at 4:30 p.m. ET.

How can I access the Schrödinger Q1 2022 earnings call?

The call can be accessed via the investors section of Schrödinger’s website.

What is Schrödinger's main business focus?

Schrödinger focuses on developing a physics-based software platform for drug and materials discovery.

How many employees does Schrödinger have?

Schrödinger has over 650 employees.

Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Stock Data

1.60B
62.15M
2.39%
96.24%
12.22%
Health Information Services
Pharmaceutical Preparations
Link
United States of America
NEW YORK